Activation of Aurora A kinase through the FGF1/FGFR signaling axis sustains the stem cell characteristics of glioblastoma cells

Experimental Cell Research

Volumn 344, Issue 2, 2016, Pages 153-166

  Hsu, Yi Chao ^a,b   Kao, Chien Yu ^a,c   Chung, Yu Fen ^a   Lee, Don Ching ^a   Liu, Jen Wei ^a,d   Chiu, Ing Ming ^a,c,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Aurora A; FGF1; Glioblastoma

Indexed keywords

3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; AURORA A KINASE; CELL SURFACE MARKER; FIBROBLAST GROWTH FACTOR 1; TOZASERTIB; VALPROIC ACID; FIBROBLAST GROWTH FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN; PIPERAZINE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTING; GLIOBLASTOMA; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL SELF-RENEWAL; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER STEM CELL; CELL DIFFERENTIATION; CELL SELF-RENEWAL; CELL SEPARATION; DRUG EFFECTS; EMBRYONIC STEM CELL; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE; MULTICELLULAR SPHEROID; MULTIPOTENT STEM CELL; NERVE CELL; PATHOLOGY; REPORTER GENE; TUMOR CELL LINE;

ANIMALS; AURORA KINASE A; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SELF RENEWAL; CELL SEPARATION; EMBRYONIC STEM CELLS; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 1; GENES, REPORTER; GLIOBLASTOMA; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MULTIPOTENT STEM CELLS; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; NEURONS; PIPERAZINES; PROMOTER REGIONS, GENETIC; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR;

EID: 84971278332     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2016.04.012     Document Type: Article

References (68)

1. Clarke J., Butowski N., Chang S. Recent advances in therapy for glioblastoma. Arch. Neurol. 2010, 67:279-283.
2. Prados M.D., Chang S.M., Butowski N., DeBoer R., Parvataneni R., Carliner H., Kabuubi P., Ayers-Ringler J., Rabbitt J., Page M., Fedoroff A., Sneed P.K., Berger M.S., McDermott M.W., Parsa A.T., Vandenberg S., James C.D., Lamborn K.R., Stokoe D., Haas-Kogan D.A. Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J. Clin. Oncol. 2009, 27:579-584.
3. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007, 67:4010-4015.
4. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64:7011-7021.
5. Gilbertson R.J., Rich J.N. Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat. Rev. Cancer 2007, 7:733-736.
6. Cho D.Y., Lin S.Z., Yang W.K., Lee H.C., Hsu D.M., Lin H.L., Chen C.C., Liu C.L., Lee W.Y., Ho L.H. Targeting cancer stem cells for treatment of glioblastoma multiforme. Cell Transplant. 2013, 22:731-739.
7. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
8. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., Lu L., Irvin D., Black K.L., Yu J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 2006, 5:67.
9. Tsai M.Y., Wiese C., Cao K., Martin O., Donovan P., Ruderman J., Prigent C., Zheng Y. A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat. Cell Biol. 2003, 5:242-248.
10. Marumoto T., Zhang D., Saya H. Aurora-A - a guardian of poles. Nat. Rev. Cancer 2005, 5:42-50.
11. Harrington E.A., Bebbington D., Moore J., Rasmussen R.K., Ajose-Adeogun A.O., Nakayama T., Graham J.A., Demur C., Hercend T., Diu-Hercend A., Su M., Golec J.M., Miller K.M. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. 2004, 10:262-267.
12. Gritsko T.M., Coppola D., Paciga J.E., Yang L., Sun M., Shelley S.A., Fiorica J.V., Nicosia S.V., Cheng J.Q. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin. Cancer Res. 2003, 9:1420-1426.
13. Barton V.N., Foreman N.K., Donson A.M., Birks D.K., Handler M.H., Vibhakar R. Aurora kinase A as a rational target for therapy in glioblastoma. J. Neurosurg. Pediatr. 2010, 6:98-105.
14. Samaras V., Stamatelli A., Samaras E., Arnaoutoglou C., Arnaoutoglou M., Stergiou I., Konstantopoulou P., Varsos V., Karameris A., Barbatis C. Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features. Pathol. Res. Pract. 2009, 205:765-773.
15. Lai C.H., Tseng J.T., Lee Y.C., Chen Y.J., Lee J.C., Lin B.W., Huang T.C., Liu Y.W., Leu T.H., Liu Y.W., Chen Y.P., Chang W.C., Hung L.Y. Translational up-regulation of Aurora-A in EGFR-overexpressed cancer. J. Cell Mol. Med. 2010, 14:1520-1531.
16. Lee D.F., Su J., Ang Y.S., Carvajal-Vergara X., Mulero-Navarro S., Pereira C.F., Gingold J., Wang H.L., Zhao R., Sevilla A., Darr H., Williamson A.J., Chang B., Niu X., Aguilo F., Flores E.R., Sher Y.P., Hung M.C., Whetton A.D., Gelb B.D., Moore K.A., Snoeck H.W., Ma'ayan A., Schaniel C., Lemischka I.R. Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling. Cell Stem Cell 2012, 11:179-194.
17. Wirtz-Peitz F., Nishimura T., Knoblich J.A. Linking cell cycle to asymmetric division: Aurora-A phosphorylates the Par complex to regulate Numb localization. Cell 2008, 135:161-173.
18. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
19. Haugsten E.M., Sorensen V., Brech A., Olsnes S., Wesche J. Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. J. Cell Sci. 2005, 118:3869-3881.
20. Liu J.W., Hsu Y.C., Kao C.Y., Su H.L., Chiu I.M. Leukemia inhibitory factor-induced Stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells. Stem Cells Dev. 2013, 22:1190-1197.
21. Myers R.L., Payson R.A., Chotani M.A., Deaven L.L., Chiu I.M. Gene structure and differential expression of acidic fibroblast growth factor mRNA: identification and distribution of four different transcripts. Oncogene 1993, 8:341-349.
22. Myers R.L., Chedid M., Tronick S.R., Chiu I.M. Different fibroblast growth factor 1 (FGF-1) transcripts in neural tissues, glioblastomas and kidney carcinoma cell lines. Oncogene 1995, 11:785-789.
23. Myers R.L., Ray S.K., Eldridge R., Chotani M.A., Chiu I.M. Functional characterization of the brain-specific FGF-1 promoter, FGF-1.B. J. Biol. Chem. 1995, 270:8257-8266.
24. Jonker J.W., Suh J.M., Atkins A.R., Ahmadian M., Li P., Whyte J., He M., Juguilon H., Yin Y.Q., Phillips C.T., Yu R.T., Olefsky J.M., Henry R.R., Downes M., Evans R.M. A PPARgamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 2012, 485:391-394.
25. Chiu I.M., Touhalisky K., Liu Y., Yates A., Frostholm A. Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter. Oncogene 2000, 19:6229-6239.
26. Chen M.S., Lin H.K., Chiu H., Lee D.C., Chung Y.F., Chiu I.M. Human FGF1 promoter is active in ependymal cells and dopaminergic neurons in the brains of F1B-GFP transgenic mice. Dev. Neurobiol. 2015, 75:232-248.
27. Hsu Y.C., Lee D.C., Chen S.L., Liao W.C., Lin J.W., Chiu W.T., Chiu I.M. Brain-specific 1B promoter of FGF1 gene facilitates the isolation of neural stem/progenitor cells with self-renewal and multipotent capacities. Dev. Dyn. 2009, 238:302-314.
28. Lee D.C., Hsu Y.C., Chung Y.F., Hsiao C.Y., Chen S.L., Chen M.S., Lin H.K., Chiu I.M. Isolation of neural stem/progenitor cells by using EGF/FGF1 and FGF1B promoter-driven green fluorescence from embryonic and adult mouse brains. Mol. Cell. Neurosci. 2009, 41:348-363.
29. Hsu Y.C., Liao W.C., Kao C.Y., Chiu I.M. Regulation of FGF1 gene promoter through transcription factor RFX1. J. Biol. Chem. 2010, 285:13885-13895.
30. Hsu Y.C., Kao C.Y., Chung Y.F., Chen M.S., Chiu I.M. Ciliogenic RFX transcription factors regulate FGF1 gene promoter. J. Cell. Biochem. 2012, 113:2511-2522.
31. Suh J.M., Jonker J.W., Ahmadian M., Goetz R., Lackey D., Osborn O., Huang Z., Liu W., Yoshihara E., van Dijk T.H., Havinga R., Fan W., Yin Y.Q., Yu R.T., Liddle C., Atkins A.R., Olefsky J.M., Mohammadi M., Downes M., Evans R.M. Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer. Nature 2014, 513:436-439.
32. Wu C.C., Yang T.Y., Yu C.T., Phan L., Ivan C., Sood A.K., Hsu S.L., Lee M.H. p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation. Cell Cycle 2012, 11:3433-3442.
33. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004, 306:1506-1507.
34. Fukuda T., Mishina Y., Walker M.P., DiAugustine R.P. Conditional transgenic system for mouse Aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein. Mol. Cell. Biol. 2005, 25:5270-5281.
35. Chotani M.A., Touhalisky K., Chiu M. The small GTPases Ras, Rac, and Cdc42 transcriptionally regulate expression of human fibroblast growth factor 1. J. Biol. Chem. 2000, 275:30432-30438.
36. Lehman N.L., O'Donnell J.P., Whiteley L.J., Stapp R.T., Lehman T.D., Roszka K.M., Schultz L.R., Williams C.J., Mikkelsen T., Brown S.L., Ecsedy J.A., Poisson L.M. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle 2012, 11:489-502.
37. Haley E.M., Kim Y. The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture. Cancer Lett. 2014, 346:1-5.
38. Manfredi M.G., Ecsedy J.A., Meetze K.A., Balani S.K., Burenkova O., Chen W., Galvin K.M., Hoar K.M., Huck J.J., LeRoy P.J., Ray E.T., Sells T.B., Stringer B., Stroud S.G., Vos T.J., Weatherhead G.S., Wysong D.R., Zhang M., Bolen J.B., Claiborne C.F. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase. Proc. Natl. Acad. Sci. USA 2007, 104:4106-4111.
39. Huang Y.-H., Wu C.-C., Chou C.-K., Huang C.-Y.F. A translational regulator, PUM2, promotes both protein stability and kinase activity of Aurora-A. PLoS One 2011, 6:e19718.
40. Buttitta L.A., Edgar B.A. Mechanisms controlling cell cycle exit upon terminal differentiation. Curr. Opin. Cell Biol. 2007, 19:697-704.
41. Berendsen S., Broekman M., Seute T., Snijders T., van Es C., de Vos F., Regli L., Robe P. Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results. Expert Opin. Investig. Drugs 2012, 21:1391-1415.
42. Kao C.Y., Hsu Y.C., Liu J.W., Lee D.C., Chung Y.F., Chiu I.M. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities. J. Neurochem. 2013, 126:4-18.
43. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
44. Vescovi A.L., Reynolds B.A., Fraser D.D., Weiss S. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 1993, 11:951-966.
45. Loilome W., Joshi A.D., ap Rhys C.M., Piccirillo S., Vescovi A.L., Gallia G.L., Riggins G.J. Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling. J. Neurooncol. 2009, 94:359-366.
46. LaVallee T.M., Prudovsky I.A., McMahon G.A., Hu X., Maciag T. Activation of the MAP kinase pathway by FGF-1 correlates with cell proliferation induction while activation of the Src pathway correlates with migration. J. Cell Biol. 1998, 141:1647-1658.
47. Hayrabedyan S., Kyurkchiev S., Kehayov I. FGF-1 and S100A13 possibly contribute to angiogenesis in endometriosis. J. Reprod. Immunol. 2005, 67:87-101.
48. Mori S., Tran V., Nishikawa K., Kaneda T., Hamada Y., Kawaguchi N., Fujita M., Saegusa J., Takada Y.K., Matsuura N., Zhao M., Takada Y. A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis. PLoS One 2013, 8:e57927.
49. Zakrzewska M., Marcinkowska E., Wiedlocha A. FGF-1: from biology through engineering to potential medical applications. Crit. Rev. Clin. Lab. Sci. 2008, 45:91-135.
50. Carmena M., Earnshaw W.C. The cellular geography of aurora kinases. Nat. Rev. Mol. Cell Biol. 2003, 4:842-854.
51. Eramo A., Ricci-Vitiani L., Zeuner A., Pallini R., Lotti F., Sette G., Pilozzi E., Larocca L.M., Peschle C., De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 2006, 13:1238-1241.
52. Zhang D., Shimizu T., Araki N., Hirota T., Yoshie M., Ogawa K., Nakagata N., Takeya M., Saya H. Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice. Oncogene 2008, 27:4305-4314.
53. Jantscher F., Pirker C., Mayer C.E., Berger W., Sutterluety H. Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities. Mol. Cancer 2011, 10:28.
54. Borges K.S., Castro-Gamero A.M., Moreno D.A., da Silva Silveira V., Brassesco M.S., de Paula Queiroz R.G., de Oliveira H.F., Carlotti C.G., Scrideli C.A., Tone L.G. Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. J. Cancer Res. Clin. Oncol. 2012, 138:405-414.
55. Pugacheva E.N., Golemis E.A. The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. Nat. Cell Biol. 2005, 7:937-946.
56. Bayliss R., Sardon T., Vernos I., Conti E. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol. Cell 2003, 12:851-862.
57. Prajapati S., Tu Z., Yamamoto Y., Gaynor R.B. IKKalpha regulates the mitotic phase of the cell cycle by modulating Aurora A phosphorylation. Cell Cycle 2006, 5:2371-2380.
58. Lefkowitz G.K., Gleeson J.G. Aurora A moonlights in neurite extension. Nat. Cell Biol. 2009, 11:1053-1054.
59. Oliveira T.M., Ahmad R., Engh R.A. VX680 binding in Aurora A: pi-pi interactions involving the conserved aromatic amino acid of the flexible glycine-rich loop. J. Phys. Chem. A 2011, 115:3895-3904.
60. Bouleau S., Grimal H., Rincheval V., Godefroy N., Mignotte B., Vayssiere J.L., Renaud F. FGF1 inhibits p53-dependent apoptosis and cell cycle arrest via an intracrine pathway. Oncogene 2005, 24:7839-7849.
61. Reynolds B.A., Tetzlaff W., Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 1992, 12:4565-4574.
62. Le Belle J.E., Orozco N.M., Paucar A.A., Saxe J.P., Mottahedeh J., Pyle A.D., Wu H., Kornblum H.I. Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. Cell Stem Cell 2011, 8:59-71.
63. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell R., Bayani J., Head R., Lee M., Bernstein M., Squire J.A., Smith A., Dirks P. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4:568-580.
64. Nakamura Y., Yamamoto M., Oda E., Yamamoto A., Kanemura Y., Hara M., Suzuki A., Yamasaki M., Okano H. Expression of tubulin beta II in neural stem/progenitor cells and radial fibers during human fetal brain development. Lab. Investig. 2003, 83:479-489.
65. Aubert J., Stavridis M.P., Tweedie S., O'Reilly M., Vierlinger K., Li M., Ghazal P., Pratt T., Mason J.O., Roy D., Smith A. Screening for mammalian neural genes via fluorescence-activated cell sorter purification of neural precursors from Sox1-GFP knock-in mice. Proc. Natl. Acad. Sci. USA 2003, 100(Suppl. 1):11836-11841.
66. Sheikh B.N., Dixon M.P., Thomas T., Voss A.K. Querkopf is a key marker of self-renewal and multipotency of adult neural stem cells. J. Cell Sci. 2012, 125:295-309.
67. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
68. Clement V., Dutoit V., Marino D., Dietrich P.Y., Radovanovic I. Limits of CD133 as a marker of glioma self-renewing cells. Int. J. Cancer 2009, 125:244-248.